Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT06374537
- Status
- Recruiting
Conditions
- Dialysis; Complications
- Frailty
- Kidney Diseases
- Pain, Chronic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Muscle Therapy — OTHERParticipants will attend 2 muscle therapy sessions a week for 12 months, for one hour each.
Study Details
This research is being done to better understand the impact of the use of a specific physical activity training program (GH Method) in dialysis/kidney disease patients.
Key Dates
- Start date
- May 22, 2019
- Status verified
- Aug 2025
- Primary completion
- May 22, 2026
- Completion
- May 31, 2027
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Investigate the effects of an exercise intervention on clinically debilitated dialysis patients.150 patients from UI Health (≥ 18 years of age), who are on dialysis, or have chronic kidney disease stage 4 (CKD 4 = GFR between 15 and 29), or have chronic kidney disease stage 5 (CKD 5 = GFR below 15) and are considered clinically debilitated by their direct healthcare professional. After the initial baseline visit, subjects will come twice weekly, for roughly 1 hour each session, for 12 months (96 visits total). Subjects will also come in for data collection visits at baseline (prior to starting the exercise program), 6 months, and 12 months. Each of those visits will take about 2-3 hours. All testing done in the 3 test visits will help assess the patient's cardiovascular and functional responses and/or changes to the exercise intervention.
- No Intervention: ControlThe control arm will receive no exercise intervention. Subjects will also come in for data collection visits at baseline (prior to starting the exercise program), 6 months, and 12 months. Each of those visits will take about 2-3 hours. All testing done in the 3 test visits will help assess the patient's cardiovascular and functional responses.
Primary Outcome Measure
Rate at which subjects will see changes in their physical abilities. [ Time Frame: 12 months ]
Central Contacts
- Ilaria Santi312-996-9594
- Natalie Isho312-996-4708
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois at Chicago | Chicago | Illinois | 60612 |
Find similar trials in Chicago, IL
By research site
Related Studies
- Diabetic Neuropathy in Spinal Cord Stimulator PatientsRecruiting · University of Chicago · Chicago, Illinois
- Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated ArthralgiaPHASE3 · Recruiting · Northwestern University · Chicago, Illinois
- Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney DiseasePHASE1/PHASE2 · Recruiting · Northwestern University · Chicago, Illinois
- Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the FutureRecruiting · International Consortium of Circulatory Assist Clinicians · San Francisco, California